Skip to content
Publications

Article · American Impact Review · February 5, 2026

Brain-centred transcriptomic convergence in autism spectrum disorder: synaptic, immune-glial and mitochondrial-transcriptional axes.

Abstract

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition in which transcriptomic findings vary across cohorts, brain regions, developmental stages, and analytical platforms. This narrative review synthesises human ASD transcriptomic evidence with primary emphasis on post-mortem cerebral cortex and examines whether recurrent biological programs emerge despite substantial heterogeneity between studies. Across cortical datasets, the most reproducible pattern is not a single universal molecular signature but partial convergence at the level of synaptic and neuronal programs, immune-glial activation, and mitochondrial-transcriptional regulation. Bulk RNA-seq has defined broad tissue-level shifts, whereas single-cell and single-nucleus approaches refine these signals at cell-type resolution and long-read transcriptomics extends interpretation to isoform structure and splicing complexity. Peripheral blood transcriptomic studies are discussed only as secondary contextual observations because immune-cell composition and clinical-state effects limit direct inference about central nervous system mechanisms. Overall, current evidence supports a brain-centred model of transcriptomic convergence in ASD that is mechanistically informative but constrained by regional specificity, cohort heterogeneity, and methodological variation.

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersChild Nutrition and Feeding Issuesautism spectrum disordermitochondrial regulationtranscriptional regulation

More by Ruslan Kurmashev